ArticleCancer management and research2018

IL-8 and thrombospondin-1 as prognostic markers in patients with metastatic colorectal cancer receiving bevacizumab.

Giorgia Marisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.